A number of aza-heterocyclic compounds, which share with members of the lamellarin alkaloids' family the 5,6-dihydropyrrolo[2,1-a]isoquinoline (DHPIQ) scaffold, were synthesized and evaluated for their ability to reverse in vitro multidrug resistance (MDR) in cancer cells, through inhibition of P-glycoprotein (P-gp) and/or multidrug-resistance-associated protein-1 (MRP-1). Most of the investigated DHPIQs proved to be selective P-gp modulators, and the most potent ones, which are 2-carbaldehydes (3 and 4) or a thiosemicarbazone derivative (10), attained submicromolar inhibition potencies (average IC50s of 0.24, 0.19 and 0.24 µM, respectively). Schiff bases prepared by condensation of some 1-aryl-DHPIQ aldehydes with p-aminophenol also proved to be of some interest, compound 15 displaying IC50 of 1.01 µM. In drug combination assays in multidrug-resistant cells, some DHPIQ compounds, at non-toxic doses, significantly increased the cytotoxicity of doxorubicin in a concentration-dependent manner. Structure-activity relationship studies and investigation of the chemical stability of the Schiff bases provided physicochemical information useful for molecular optimization of lamellarin-like cytotoxic drugs active toward chemoresistant tumors as well as non-toxic reversers of P-gp-mediated MDR in tumor cells.

A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells

Altomare, Cosimo Damiano;Niso, Mauro;Colabufo, Nicola Antonio;Boccarelli, Angelina;Purgatorio, Rosa;de Candia, Modesto;Cellamare, Saverio;
2018-01-01

Abstract

A number of aza-heterocyclic compounds, which share with members of the lamellarin alkaloids' family the 5,6-dihydropyrrolo[2,1-a]isoquinoline (DHPIQ) scaffold, were synthesized and evaluated for their ability to reverse in vitro multidrug resistance (MDR) in cancer cells, through inhibition of P-glycoprotein (P-gp) and/or multidrug-resistance-associated protein-1 (MRP-1). Most of the investigated DHPIQs proved to be selective P-gp modulators, and the most potent ones, which are 2-carbaldehydes (3 and 4) or a thiosemicarbazone derivative (10), attained submicromolar inhibition potencies (average IC50s of 0.24, 0.19 and 0.24 µM, respectively). Schiff bases prepared by condensation of some 1-aryl-DHPIQ aldehydes with p-aminophenol also proved to be of some interest, compound 15 displaying IC50 of 1.01 µM. In drug combination assays in multidrug-resistant cells, some DHPIQ compounds, at non-toxic doses, significantly increased the cytotoxicity of doxorubicin in a concentration-dependent manner. Structure-activity relationship studies and investigation of the chemical stability of the Schiff bases provided physicochemical information useful for molecular optimization of lamellarin-like cytotoxic drugs active toward chemoresistant tumors as well as non-toxic reversers of P-gp-mediated MDR in tumor cells.
File in questo prodotto:
File Dimensione Formato  
Altomare_et_al-2018-ChemMedChem.pdf

non disponibili

Tipologia: Documento in Versione Editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 925.86 kB
Formato Adobe PDF
925.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Nevskaya et al., ChemMedChem 2018_Preprint.pdf

accesso aperto

Tipologia: Documento in Pre-print
Licenza: Creative commons
Dimensione 573.96 kB
Formato Adobe PDF
573.96 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/218640
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact